- Today2017September 2010
Chief Executive OfficerValencia Technologies Corporation
- TodayMay 2010September 1992
Advanced Bionics/President /CEOAdvanced Bionics
- TodaySeptember 1992July 1986
Associate General CounselSiemens-Pacesetter
- TodayJune 1986August 1983
Assistant Judge AdvocateUnited States Air Force
- The George Washington University Law School, Washington
The George Washington University Law SchoolMaster of Laws (LLM)
- TodayJuly 1982July 1977
Chief Military Counsel for Japan and KoreaUnited States Air Force
- UCLA School Of Law, Los Angeles
UCLA School of LawJuris Doctor
United States Air Force AcademyBachelor of Science
Please sign up to view Jeffrey Greiner Advanced Bionics's full profile.SIGN UP
- Medical technology
- Neuromodulation technology
An executive leader in medical technology development, Jeff Greiner began working in the industry in the mid 1980s as general counsel at Siemens-Pacesetter Systems. In 1992, he joined a small Los Angeles area start-up called Advanced Bionics as chief operating officer. Over the next 18 years, Greiner played a critical role in growing that start-up from a handful of scientists and engineers to a global powerhouse in neuromodulation.
Greiner served as president and chief executive officer at the height of Advanced Bionics’ success during the 2000s. At that time, the company produced revenues in excess of $300 million. In the late 2000s, Boston Scientific purchased Advanced Bionics’ neuromodulation division and Sonova bought the company’s cochlear implant unit. The latter continues to create devices that help deaf and near-deaf people to hear.
Today, Jeff Greiner serves as the CEO of the neuromodulation technology pioneer Valencia Technologies Corporation. The company, which recently completed a new Class III medical product manufacturing site, will begin testing its technology in an international feasibility clinical trial in summer 2013.